George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’. Watch the video here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFuture Regulatory News (FUTR)

Share Price Information for Future (FUTR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 609.00
Bid: 609.50
Ask: 610.50
Change: -6.50 (-1.06%)
Spread: 1.00 (0.164%)
Open: 617.00
High: 628.50
Low: 605.50
Prev. Close: 615.50
FUTR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.3 - Future plc

12 Jan 2021 13:47

RNS Number : 4351L
JPMorgan Asset Management
12 January 2021
 
FORM 8.3

 

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Full name of discloser:

JPMorgan Asset Management

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

N/A

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Future plc

(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:

N/A

(e) Date position held/dealing undertaken:

For an opening position disclosure, state the latest practicable date prior to the disclosure

11 January 2021

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

Yes, GoCo Group plc

 

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

 

Class of relevant security:

 

15p ordinary

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

6,600,375

6.73

(2) Cash-settled derivatives:

 

332,152

0.34

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

 

TOTAL:

6,932,527

7.07

 

All interests and all short positions should be disclosed.

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

(b) Rights to subscribe for new securities (including directors' and other employee options)

 

Class of relevant security in relation to which subscription right exists:

Details, including nature of the rights concerned and relevant percentages:

 

 

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

 

Class of relevant security

Purchase/sale

 

Number of securities

Price per unit

Ordinary Shares

Sale

5,442

18.1423 GBP

 

(b) Cash-settled derivative transactions

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

 

 

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

(ii) Exercise

 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

 

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

 

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

none

 

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

none

 

 

 

(c) Attachments

 

Is a Supplemental Form 8 (Open Positions) attached?

No

 

 

Date of disclosure:

12 January 2021

Contact name:

 

Daniel Swart

Telephone number*:

 

0207 134 6168

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

 

*If the discloser is a natural person, a telephone number does not need to be included, provided contact information has been provided to the Panel's Market Surveillance Unit.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RETBTMJTMTIBBAB
Date   Source Headline
12th May 202210:37 amRNSHolding(s) in Company
10th May 20227:00 amRNSAcquisition of WhoWhatWear
29th Apr 20229:49 amRNSTotal Voting Rights
19th Apr 202211:00 amRNSNotice of Results
31st Mar 202211:03 amRNSTotal Voting Rights
24th Mar 20227:00 amRNSAcquisitions of WhatCulture.com & Waive
28th Feb 202210:28 amRNSTotal Voting Rights
17th Feb 20227:00 amRNSFurther re Rule 19.6(c) confirmation
11th Feb 202210:07 amRNSHolding(s) in Company
11th Feb 202210:06 amRNSDirector/PDMR Shareholding
8th Feb 20228:49 amRNSInvestor webinar
3rd Feb 20221:38 pmRNSDirector/PDMR Shareholding
3rd Feb 20221:36 pmRNSResult of AGM
3rd Feb 20227:00 amRNSTrading Update
31st Jan 20229:52 amRNSTotal Voting Rights
31st Jan 20229:51 amRNSHolding(s) in Company
25th Jan 202212:00 pmRNSInvestor webinar
17th Jan 20223:45 pmRNSHolding(s) in Company
4th Jan 202210:58 amRNSBlock listing Interim Review
4th Jan 202210:54 amRNSTotal Voting Rights
17th Dec 202111:52 amRNSAdditional Listing
15th Dec 20217:00 amRNSDirector/PDMR Shareholding
14th Dec 20213:58 pmRNSAnnual Financial Report
9th Dec 20217:00 amRNSLaunch of Responsibility Strategy
1st Dec 202110:47 amRNSTotal Voting Rights
30th Nov 20217:00 amRNSFull Year Results
1st Nov 20213:35 pmRNSTotal Voting Rights
14th Oct 202111:00 amRNSAppointment of Joint Corporate Broker
4th Oct 20217:00 amRNSFull-year performance update & directorate change
1st Oct 20219:21 amRNSTotal Voting Rights
24th Sep 202111:00 amRNSInvestor Webinar
1st Sep 20219:26 amRNSTotal Voting Rights
19th Aug 20219:45 amRNSHolding(s) in Company
16th Aug 20217:00 amRNSAcquisition of Dennis
2nd Aug 20217:00 amRNSTotal Voting Rights and Share Capital
26th Jul 202112:20 pmRNSDirector Declaration
21st Jul 20217:00 amRNSTrading Update
15th Jul 202110:14 amRNSDirector Declaration
1st Jul 20219:30 amRNSBlock listing Interim Review
1st Jul 20219:28 amRNSTotal Voting Rights
10th Jun 20212:59 pmRNSHolding(s) in Company
4th Jun 20217:00 amRNSDirector/PDMR Shareholding
3rd Jun 20215:21 pmRNSDirector/PDMR Shareholding
3rd Jun 20218:35 amRNSHolding(s) in Company
1st Jun 20219:08 amRNSTotal Voting Rights
26th May 20214:21 pmRNSHolding(s) in Company
19th May 20217:00 amRNSHalf Year Results
12th May 20217:00 amRNSAcquisition of Marie-Claire US
11th May 20217:00 amRNSNotice of Results
4th May 20217:00 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.